S&P 500   4,541.11 (-0.21%)
DOW   35,689.32 (+0.73%)
QQQ   386.80 (-0.77%)
AAPL   188.36 (-0.53%)
MSFT   376.59 (-0.60%)
META   323.68 (-2.56%)
GOOGL   131.64 (-2.48%)
AMZN   145.01 (-0.90%)
TSLA   240.38 (-1.54%)
NVDA   466.18 (-3.16%)
NIO   7.19 (+0.14%)
BABA   74.38 (-0.39%)
AMD   120.37 (-2.81%)
T   16.44 (+0.86%)
F   10.26 (-3.12%)
MU   75.61 (-1.41%)
CGC   0.56 (-0.64%)
GE   120.43 (+1.32%)
DIS   92.54 (+0.04%)
AMC   6.81 (-5.02%)
PFE   30.40 (+1.06%)
PYPL   57.23 (-1.28%)
XOM   102.61 (+0.26%)
S&P 500   4,541.11 (-0.21%)
DOW   35,689.32 (+0.73%)
QQQ   386.80 (-0.77%)
AAPL   188.36 (-0.53%)
MSFT   376.59 (-0.60%)
META   323.68 (-2.56%)
GOOGL   131.64 (-2.48%)
AMZN   145.01 (-0.90%)
TSLA   240.38 (-1.54%)
NVDA   466.18 (-3.16%)
NIO   7.19 (+0.14%)
BABA   74.38 (-0.39%)
AMD   120.37 (-2.81%)
T   16.44 (+0.86%)
F   10.26 (-3.12%)
MU   75.61 (-1.41%)
CGC   0.56 (-0.64%)
GE   120.43 (+1.32%)
DIS   92.54 (+0.04%)
AMC   6.81 (-5.02%)
PFE   30.40 (+1.06%)
PYPL   57.23 (-1.28%)
XOM   102.61 (+0.26%)
S&P 500   4,541.11 (-0.21%)
DOW   35,689.32 (+0.73%)
QQQ   386.80 (-0.77%)
AAPL   188.36 (-0.53%)
MSFT   376.59 (-0.60%)
META   323.68 (-2.56%)
GOOGL   131.64 (-2.48%)
AMZN   145.01 (-0.90%)
TSLA   240.38 (-1.54%)
NVDA   466.18 (-3.16%)
NIO   7.19 (+0.14%)
BABA   74.38 (-0.39%)
AMD   120.37 (-2.81%)
T   16.44 (+0.86%)
F   10.26 (-3.12%)
MU   75.61 (-1.41%)
CGC   0.56 (-0.64%)
GE   120.43 (+1.32%)
DIS   92.54 (+0.04%)
AMC   6.81 (-5.02%)
PFE   30.40 (+1.06%)
PYPL   57.23 (-1.28%)
XOM   102.61 (+0.26%)
S&P 500   4,541.11 (-0.21%)
DOW   35,689.32 (+0.73%)
QQQ   386.80 (-0.77%)
AAPL   188.36 (-0.53%)
MSFT   376.59 (-0.60%)
META   323.68 (-2.56%)
GOOGL   131.64 (-2.48%)
AMZN   145.01 (-0.90%)
TSLA   240.38 (-1.54%)
NVDA   466.18 (-3.16%)
NIO   7.19 (+0.14%)
BABA   74.38 (-0.39%)
AMD   120.37 (-2.81%)
T   16.44 (+0.86%)
F   10.26 (-3.12%)
MU   75.61 (-1.41%)
CGC   0.56 (-0.64%)
GE   120.43 (+1.32%)
DIS   92.54 (+0.04%)
AMC   6.81 (-5.02%)
PFE   30.40 (+1.06%)
PYPL   57.23 (-1.28%)
XOM   102.61 (+0.26%)

Seelos Therapeutics (SEEL) Earnings Date, Estimates & Call Transcripts

$1.11
-0.14 (-11.20%)
(As of 01:03 PM ET)
Compare
Today's Range
$1.04
▼
$1.34
50-Day Range
$1.25
▼
$6.46
52-Week Range
$1.04
▼
$49.80
Volume
2.62 million shs
Average Volume
111,104 shs
Market Capitalization
$5.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$70.00
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

SEEL Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SEEL Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

SEEL Earnings Date and Information

Seelos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off prior year's report dates.

Seelos Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/13/2024
Estimated)		------- 
5/15/2023Q1 2023-($3.60)($3.60)($0.12)-$0.81 million
11/10/2022Q3 2022-($5.40)($5.40)($0.18)--
8/5/2022Q2 2022($9.00)($6.00)+$3.00($0.20)--
5/10/2022Q1 2022($8.40)($3.90)+$4.50($0.13)--
3/4/2022Q4 2021-($8.40)($8.40)($0.28)--
11/5/2021Q3 2021($2.70)($3.30)($0.60)($0.11)--
8/9/2021Q2 2021($5.10)($2.40)+$2.70($0.06)--
4/30/2021Q1 2021-($8.40)($8.40)($0.28)--
3/11/2021Q4 2020-($3.90)($3.90)($0.13)--












Seelos Therapeutics Earnings - Frequently Asked Questions

When is Seelos Therapeutics's earnings date?

Seelos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off last year's report dates. Learn more on SEEL's earnings history.

How much profit does Seelos Therapeutics generate each year?

Seelos Therapeutics (NASDAQ:SEEL) has a recorded net income of -$73.53 million. SEEL has generated $0.00 earnings per share over the last four quarters.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:SEEL) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -